Orientation Material for M8: ectd EWG ectd v4.0 Implementation Package v1.3

Similar documents
ectd Next Major Version Business Requirements (11-JUN-09)

ectd Next Major Release Business Requirements Collation (9-JUN-10) TOPIC Requirement Comment

ectd Next Major Release Business Requirements Collation (11 NOV 10) TOPIC Requirement Comment ICH Req No.

RPS/ICH Requirements. sequence number values would need to be unique to each application. principle. 1 of 14

Steps to RPS Adoption

1. Document Control 2. Change Record Version Date Author(s) Comments 3. Reviewers Version Name Organisation 4. Distribution Version Date Name Status

ectd TECHNICAL CONFORMANCE GUIDE

Get ready for ectd in South Africa. Current status at MCC

Work instructions for US-FDA ANDA Submissions Work Instructions for ectd US-FDA ANDA Submissions

1 2 December esubmissions? 1. How can baseline dossiers support global esubmissions? Disclaimer. What is a baseline submission?

ICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD. Step 5

ICH M8 Expert Working Group. ICH Electronic Common Technical Document (ectd) v4.0 Implementation Guide v1.2

A CMC Reviewer s Perspective on the Quality Overall Summary. Arthur B. Shaw, Ph.D. FDA/CDER/ONDQA FDA DMF Expert June 15, 2010.

US Food and Drug Administration. Revision History

MEDICINES CONTROL COUNCIL

ICH M8 Expert Working Group. ICH Electronic Common Technical Document (ectd) v4.0 DRAFT ICH Implementation Guide v2.0

ectd Next Major Version / Regulated Product Submission

M2 Glossary of Terms and Abbreviations

Guidance for Industry on Providing Regulatory Information in Electronic Format: ectd electronic Submissions

Submitting High Quality ectd Submissions to FDA/OGD

-Evolving ectd Technology Transforming Global Regulatory Submission Strategy. PART TWO 30-Mar ectd MASTERCLASS 1

Release Notes for TIGes ectd Guidance Comparison of version 2.0 with 1.0

Preparing for FDA Mandated ectd Submissions

ectd : Industry Experience

Biotechnology Industry Organization 1225 Eye Street NW, Suite 400 Washington, DC 20006

Change Control Process for European ectd Standards Version 1.1. December 2006

Revision of Technical Conformance Guide on Electronic Study Data Submissions

MedDRA BEST PRACTICES. Maintenance and Support Services Organization s (MSSO) Recommendations for Implementation and Use of MedDRA

Guidance for electronic submissions for Certificates of Suitability (CEP) applications

MEDICINES CONTROL COUNCIL

Get ready for ectd in South Africa

ICH M8 Expert Working Group. Specification for Submission Formats for ectd v1.1

The ectd Backbone Files Specification for Module 1. The ectd BACKBONE FILES SPECIFICATION FOR MODULE 1

Frequently Asked Questions (FAQs)

Introduction to the Points to Consider Documents. MedDRA trademark is owned by IFPMA on behalf of ICH

MedDRA Developer Webinar

Case Study Update on Structured Content Approaches at Genzyme

GDUFA s Impact on ectds / Case Study: Implementing PDF Standards

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

Guidance for electronic and paper submissions for Certificates of Suitability (CEP) applications

Common Statistical Analysis Plan (SAP) Frequently Asked Questions

MedDRA Version Updates. MedDRA trademark is owned by IFPMA on behalf of ICH

Biocides Submission Manual

JORDAN Module 1 ectd Specification Version 1.0.1

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE

MEDICINES CONTROL COUNCIL

ectd in Canada Ginette Larocque, Purdue Pharma Canada August 23, 2016

IUCLID 6. Release notes. Version /6/2016

EMA Common Repository: Questions and answers relating to practical and technical aspects of the implementation

EXEMPTIONS: PROCEDURE TO BE FOLLOWED FOR MEDICINES FOR HUMAN USE

Webinar IUCLID 6 Questions and Answers

Complementary Medicines. Registration: Process, Format and Requirements

Recent Developments in FDA s Review of Proprietary Names for Drugs

Submission of information in the public consultation on potential candidates for substitution under the Biocidal Products Regulation

MEDICINES CONTROL COUNCIL

Chapter 10: Regulatory Documentation

Guidance for Industry on Providing Regulatory Information in Electronic Format: Non-eCTD electronic Submissions (NeeS) for human medicinal products

ectd Tools Compatibility and Interoperability: Discussion and Practical Experience

Important Notes: The XML and there corresponding images should be added with the proper file names.

Guideline on the specifications for provision of an electronic submission (e-submission) for a veterinary medicinal product

Managing your metadata efficiently - a structured way to organise and frontload your analysis and submission data

Variations in ectd format Q&A document

Questions & Answers on Swissmedic ectd Implementation

Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH M2 EWG

Guidance for Industry on Providing Regulatory Information in ectd Format

MEDICINES CONTROL COUNCIL

extended EudraVigilance Medicinal Product Dictionary (XEVMPD) e-learning

extended EudraVigilance Medicinal Product Report Message (XEVPRM) Step-by-Step Guide

esubmission Gateway and Web Client Training on the use of XML delivery files for Veterinary submissions

Zambia Medicines Regulatory Authority APPLICATION FOR MARKETING AUTHORISATION OF A MEDICINE FOR HUMAN USE

By Cornelia Wawretchek. The Drug Manufacturer s Guide to Site Master Files

HYCU SCOM Management Pack for F5 BIG-IP

ACKNOWLEDGMENTS BEST PRACTICE

About Domestic Implementation of the Electronic File Specifications to Be Included in the ICH Electronic Common Technical Document (ectd) v1.1.

Node 2.0 FCD Compatibility Guideline Development

User Guide 16-Mar-2018

AHRQ PSO Information Form. Technical Specifications for XML. Data Submission from PSO to PSOPPC

Session 4. Workshop on the implementation of ISO standard for ICSRs. Testing with EMA new process

Update of ectd Module 1 specification for South Africa V2.0

TH ectd Specification

Pre-notification check for type IB Variations 1

Lex Jansen Octagon Research Solutions, Inc.

An Alternate Way to Create the Standard SDTM Domains

PSUR Repository Interactive Q&A

SAS Clinical Data Integration Server 2.1

Criteria Webinar. 13 th July European Update on Validation of ectd & NeeS submissions, July 2012

SecureAware Compliance Analysis Manual

Oracle Argus Safety. Service Administrator s Guide Release E

NERC Transmission Availability Data System (TADS): Element Identifier Data Submission Addendum

Measures for Article 57 Data Quality Assurance

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) GUIDELINE ON REQUIREMENTS FOR PLASMA MASTER FILE (PMF) CERTIFICATION

Quality Overall Summary Chemical Entities Clinical Trial Application Phase III QOS - CTA GRP(PQ)-01-1(v1): Date 2008/11/12

vendor guide CONNECTED DEVICES HELP CONTROL ELECTRICITY USE Smart Meter Connected Devices Service LOOK WHAT YOUR HOME S SMART METER CAN DO FOR YOU

BEST PRACTICE GUIDE ON THE USE OF THE ELECTRONIC COMMON TECHNICAL DOCUMENT

European Single Electronic Format (ESEF) Eurofiling workshop 8 June 2017

QUALITY OVERALL SUMMARY - CHEMICAL ENTITIES (Applications for Drug Identification Number Submissions) (QOS-CE (DINA))

Customer Guidance For Requesting Changes to SNOMED CT

The WIN applies to the Vet Applications team in the Veterinary Regulatory and Organisational Support service (V-VM-ROS).

Transcription:

Orientation Material for M8: ectd EWG ectd v4.0 Implementation Package v1.3 International Council on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1

Legal Notice This presentation is protected by copyright and may be used, reproduced, incorporated into other works, adapted, modified, translated or distributed under a public license provided that ICH's copyright in the presentation is acknowledged at all times. In case of any adaption, modification or translation of the presentation, reasonable steps must be taken to clearly label, demarcate or otherwise identify that changes were made to or based on the original presentation. Any impression that the adaption, modification or translation of the original presentation is endorsed or sponsored by the ICH must be avoided. The presentation is provided "as is" without warranty of any kind. In no event shall the ICH or the authors of the original presentation be liable for any claim, damages or other liability arising from the use of the presentation. 2

Document History June 2016 November 2016 October 2018 First release based on the Implementation Package v1.1 Updated based on the Implementation Package v1.2 Updated based on the Implementation Package v1.3 3

Table of Contents 1. Objectives of this presentation 2. Concepts and Benefits 3. Transition from v3.2.2 to ectd v4.0 4. Region-specific Topics 5. Advantages of ectd v4.0 4

1. Objectives of this presentation 5

1.1 Objectives of this presentation Target audience o Business personnel and management involved in any aspect of ectd submission design and preparation. Provide an overview of: o ectd v4.0 concepts and benefits in plain language o High level considerations for transitioning from v3.2.2 to ectd v4.0 6

2. ectd Concepts and Benefits 7

2.1 Key Messages With ectd v4.0, you can o Re-use documents submitted previously, o Correct information (e.g. display name or document title) easily, o Group documents within a CTD section in a consistent way across ICH regions, o Change document granularity while maintaining life cycle relationships, o Set the order of documents within a CTD section, o Identify submission content (e.g., datasets) for additional processing, and o Transition current content in v3.2.2 to v4.0 and continue ectd life cycle in v4.0. 8

2.2 ectd v4.0 Concepts a. Application/Submission b. Controlled Vocabulary c. Keywords and Keyword Definitions d. Context of Use f. Document Label g. Document h. Group Title i. Study Group Order e. Ordering Content

a. Application Submission Submission Unit 10

Application-submission-submission unit relationship The application is primarily a Module 1 concept and is described in the Regional/Module 1 Implementation Guide. In some regions it represents the concerned products with all their strengths and pharmaceutical forms as decided by the applicant to be combined within one dossier considering the most effective life cycle approach. In other regions it represents a superordinate concept that covers one or multiple products that share a common set of documents for review. The submission is primarily a Module 1 concept and described in the Regional/Module 1 Implementation Guide. In some regions it represents a regulatory activity such as new marketing authorisation application or renewal for that one application. In other regions it represents almost the same as the application. The submission unit covers all content submitted at one time point related to the submission, e.g. all required information for a new application or to respond to a list of questions during the assessment of that new application. 11

ICH ectd v4.0 - Big Picture 3-layered Structure Application Submission Submission Submission Unit Submission Unit Submission Unit Submission Unit Submission Unit Submission Unit 12

ICH ectd v4.0 Big Picture Applicant submits Submission Unit to Regulator o A Submission Unit has the information about the Submission and Application to which it belongs. Applicant Regulator ICH ectd v4.0 Message Application Application Submission Submission Unit Submission Unit Submission Unit Submission Application Submission Submission Unit Submission Unit Note: Two-way communication is excluded from ICH business cases. 13

b. Controlled Vocabulary 14

Controlled vocabularies (CV) A controlled vocabulary (CV) is a list of allowed terms for a specific concept. Each CV is maintained by a specific organization that establishes and updates the allowed terms. 5 types of CVs for ectd v4.0 o Specified by ICH o Specified Regionally o Specified by HL7 o Specified by External Organization o Sender-defined 15

Controlled vocabularies (CV) Examples of controlled vocabularies: o o ICH CV for species - Mouse, rat, dog, etc. US regional CV for application - NDA, IND, ANDA, BLA, etc. Examples of CVs that are new for v4.0 o o o o Category Event* to provide additional structured information about the submission unit contents Document Types replace file tag valid values (e.g., preclinical study report, study report synopsis) Media Type to provide additional information to be used for processing the documents (e.g., study data files) Study Group Order to provide a mechanism to order studies when the Study ID and Study Title keyword is used (refer to slide #39) * See Regional CV list for values 16

Fewer system updates expected CTD or regional structure updates will be based on controlled vocabularies. o Allow implementation of changes to the CTD Table of Contents (TOC) and associated keywords o Greater flexibility to meet evolving business practices, but some system updates may be warranted o Business Rules may still require new logic and/or checks. o Updates to controlled vocabulary may require the retirement of obsolete terms. 17

c. Keyword and Keyword Definitions 18

Keyword and keyword definition Additional information used to organize documents within a TOC heading/section Keyword o List of allowed terms is provided (Controlled Vocabulary) - e.g., list of terms for type of control is defined by ICH. o Reference to a sender-defined keyword definition Keyword definition o Sender defines list of terms - e.g., company 1, company 2 for manufacturer 19

Update keyworddefinition displayname Updates can be made for typos or errors to the displayname Possible views on the tool Sequence 1 Sequence 2 Module X mx.x CTD Heading mx.x.x CTD Heading Title (Ace Manufacturer) mx.x.x.x CTD Heading Title Document Title Module X mx.x CTD Heading mx.x.x CTD Heading Title (Acme Manufacturer) mx.x.x.x CTD Heading Title Document Title displayname Updated Note: ICH doesn't define any view on any tool. Tool design is at the discretion of the tool vendors. 20

d. Context of Use 21

Context of Use (COU) Placement of a document within a TOC heading/section Provides information regarding the usage of a document and its life cycle (e.g., content may be replaced). Keyword gives additional information to the CoU. Example: COU X 3.2.S.2 Manufacture (name 1, manufacturer 1) 22

CoU and Keyword Combinations The combination of CoU and keyword(s) defines the context of the submission contents. If any one of them is different, the context is considered different. COU X 3.2.S.2 Manufacture Substance 1, manufacturer 1) COU Y 3.2.S.2 Manufacture Substance 1, manufacturer 2) Module 3 Possible view in the tool 3.2 Body of Data 3.2.S Drug Substance (Substance 1) 3.2.s.2 Manufacture (Manufacturer 1) Document Title 1 3.2.s.2 Manufacture (Manufacturer 2) Document Title 2 Note: ICH doesn't define any view on any tool. Tool design is at the discretion of the tool vendors. 23

Life cycle operators Active, Replace and Suspend (previously New, Replace, Delete) - valid life cycle operators in ectd v4.0 Append life cycle operator omitted from ectd v4.0 o The applicant should take into consideration the removal of the append life cycle operator when developing a strategy to manage the life cycle of documents in ectd v4.0. 24

Life cycle operator - Replace Replace one document with one document Replace one document with many documents Replace many documents with one document Life cycle relationship is maintained on all documents 25

e. Ordering Content (Priority Number) 26

Set the order of documents within a CTD section Using Priority number Explicitly define the display order of Context of Use in a specific section Defines the order of display for each Combination of CoU and keyword(s) in a given CTD section Sender may reorder submission content or insert submission content into a specific order within the existing content over time Similar view on end-users' screen 27

Update Priority Number Possible views on the tool Sequence 1 Sequence 2 Module X mx.x CTD Heading mx.x.x CTD Heading Title (keyword displayname) mx.x.x.x CTD Heading Title Document Title 1 Document Title 2 Document Title 3 Document Title 5 Module X mx.x CTD Heading mx.x.x CTD Heading Title (keyword displayname) mx.x.x.x CTD Heading Title Order Updated! Document Title 5 Document Title 1 Document Title 3 Document Title 2 Note: ICH doesn't define any view on any tool. Tool design is at the discretion of the tool vendors. 28

f. Document Label 29

Document Label Sender-defined value to abbreviate the document title Value is associated with the Context of Use Document Label addresses issues with the length or similar values given for document title o Document title may be too long or too generic to quickly identify contents with review staff Value does not impact priority number for ordering 30

Apply Document Label Senders can use the document label to provide a short document name for easier reference Module 3 Quality m3.2 Body of data Possible views in the tool m3.2.p Drug product (product 1 manufacturer 1) m3.2.p.7 Container closure system (blister) (3.2.p.7-1) Document Title 1 (3.2.p.7-2) Document Title 2 (3.2.p.7-3) Document Title 3 (3.2.p.7-4) Document Title 4 Note: ICH doesn't define any view on any tool. Tool design is at the discretion of the tool vendors. 31

g. Documents 32

Reuse documents previously submitted Unique identifier approach means documents can be referenced/reused more effectively without resubmitting the physical file o o o Across a Submission Unit (Sequence) Across regulatory activities within an application Across different applications Used to reference the document in a context of use Reuse of document metadata (e.g., document title, language, media type) Allows the reuse of documents with a reference to the identifier instead of the resubmission of the documents 33

Update Document title Update keyword definition display name, document title, etc. o e.g., fix typo Possible views on the tool Sequence 1 Sequence 2 Module X mx.x CTD Heading mx.x.x CTD Heading Title (keyword displayname) mx.x.x.x CTD Heading Title Manufact Process and Controls Module X mx.x CTD Heading mx.x.x CTD Heading Title (keyword displayname) mx.x.x.x CTD Heading Title Manufacturing Process and Controls Title Updated! Note: ICH doesn't define any view on any tool. Tool's design is at the discretion of the tool vendors. 34

h. Group Title 35

Grouping of content in a CTD section Uses Group Title Keyword Applied to a Context of Use or Context of Use and Keyword combination to further organize content under a CTD heading when multiple documents are allowed The sender assigns the group title and priority number to specify how the content should appear together in a particular order 36

Apply Group Title Possible views in the tool Senders can use group title based on M4 Granularity Document where One or multiple documents can be submitted Replaces regional implementation of Node Extensions Module 3 Quality m3.2 Body of data m3.2.p Drug product (product 1 manufacturer 1) m3.2.p.7 Container closure system (blister) Group Title 1 Document Title 1 Document Title 2 Document Title 3 Document Title 4 Group Title 2 Document Title 5 Document Title 6 Note: ICH doesn't define any view on any tool. Tool design is at the discretion of the tool vendors. 37

i. Study Group Order 38

Set order of Studies in a CTD section Uses Study Group Order Keyword with code values from 1 to 99 Provides a mechanism to define the order that studies will be displayed in Modules 4 & 5 The study group order keyword should only be used with the study id_study title keyword Ability to order studies in a particular CTD section 39

Apply Study Group Order Possible views in the tool Senders can use the study group order keyword to add sequential ordering of study groups Applies to headings with a study identifier/study title keyword Module 4 Study m4.2.1 1 primary pharmacodynamics study id_study_title (Study Group Order 1) document type Group Title 1 Document Title 1 Group Title 2 Document Title 2 study id_study_title (Study Group Order 2) document type Group Title 3 Document Title 3 Group Title 4 Document Title 4 Note: ICH doesn't define any view on any tool. Tool design is at the discretion of the tool vendors. 40

3. Transition from v3.2.2 to v4.0 41

Transition Mapping Message What is Transition Mapping Message (TMM)? o The message submitted from the applicant to regulator when the application needs to transition from v3.2.2 to ectd v4.0 format during its life cycle. v3.2.2 Applicant Sequence 0000 v3.2.2 Regulator Sequence 0001 Without TMM, the applicant cannot transition to v4.0 TMM V4.0 Mapping current v3.2.2 content to v4.0 Sequence 3 42

How transition will work (high-level) Submit ectd sequence- transition mapping message (TMM) o Current ectd view will be transitioned. - Only submission content that has been submitted to the Regulatory Authority in ectd format - All current submission contents should be transitioned regardless of whether or not the content will undergo life cycle. Exclude deleted or replaced leafs Includes append leafs - No changes included in transition message, make changes before or afterward but not in TMM. - No content files should be submitted for the transition mapping message 43

Purpose of the transition message Enable Context of Use life cycle Enable reuse of documents Want to retire v3.2.2 in the future 44

Considerations before transitioning to v.4.0 Develop a strategy for managing sender-defined keywords. o o o Note this will allow for better utilization of grouped submissions when allowed in certain regions. Recommend that keywords be managed across applications even though they need to be sent for each application. Combine individual Study ID and Study Title keyword values. Ensure that the Transition Mapping Message is accepted by the Regulator before sending v4.0 message Only one valid TMM will be allowed i.e., once the content is transitioned and the first v4.0 message is received, only v4.0 messages will be processed for that application. 45

Tools needed to create and view v4.0 submissions Tools required to create/manage and view ectd v4.0 In comparison to ectd v3.2.2, o No longer possible to manually create a pilot/sample submission. o Difficult to make manual corrections/fixes o Stylesheets will not be provided to view ectd v4.0 content ectd v4.0 submissions much more complex to create without tools 46

4. Region-specific Topics 47

Region-specific Topics Grouped submissions vary by region and may be: o A single Submission Unit with multiple Submission components o Multiple Submission Units included in one transmission (i.e., one Submission Unit for each Submission) Communication with regulators - The regulatory authority can send correspondence to the submitter via ectd v4.0. o Applicants may receive and store sequences from regulatory authority along with applicant s submission contents. 48

5. Advantages of ectd v.4.0 49

Advantages of ectd v4.0 Harmonised submission unit: o All content from Module 1 through Module 5 is contained in one exchange message i.e., an XML file covers both ICH and regional information. Document reuse: o Once a document has been submitted, the document may be reused by referencing its unique identifier (ID) from the same or different submission unit. o o Allows reuse of meta-data (e.g., document title, language, media type) All the contents of the reused document, including references and hypertext links to other documents, should be relevant to the submission that reuses the document. Context of Use life cycle: o The Context of Use concept allows for advanced life cycle management operations. A Context of Use may be replaced by one or more Context of Use elements and vice versa (i.e., one to many, many to one) through the context of use life cycle. o ectd v4.0 also introduces the ability to apply changes to keyword definition display name values (e.g., drug substance/product names, manufacturers, dosage forms, indication, excipient, group title, etc.) without resubmitting the physical files or the Context of Use element. 50

Advantages of ectd v4.0 Function of context of use and keyword combinations: o The Context of Use and Keyword combination will function to create a group of documents. o One use of context groups includes the replacement for STFs in Modules 4 and 5 to organise multiple files relating to a single clinical study as noted in the ectd specification v3.2.2. Controlled vocabularies (CVs): o Allowed values are captured in CVs providing for easier update without the need for system or tool updates o For sender-defined keyword values, previously submitted values can be corrected/replaced in subsequent submissions Additional document metadata o Document metadata may be used to identify submission content (e.g., datasets) that require additional processing 51